Bioanalytical Method Development

Event Information

Registration

Online Registration is open!
Register Now!

Conference Brochure

Download Brochure
Event Details Inside

Send To A Friend

Invite a colleague to join you at this event
Send to Friend

Related Events

Find another IIR Event

Event Search Form by Industry

Advanced Search

Customer Service

Have a question about this event?
Customer Service representatives are available to help from 8 AM - 6 PM EST
Call 888-670-8200
------------------------------------
Need Technical Assistance With this Website?
Send an email to IIR's Web Department

Add Event To Calendar

Save the event dates in your Outlook calendar
Add to Outlook Diary

Home

Home

This conference is the ONLY event of it’s kind and offers best practices for obtaining biomolecular interactions data, PK assay development strategies for non-clinical vs.clinical, BioAnalytical strategies for antibody-drug conjugates, and best practices for Fc functionality assessment. The industry asked for the conference as one like this has never been done before focusing specifically on these specific high level topics. Our first event in 2008 was a success and we look forward to building upon this success in 2009. This meeting is a unique forum for industry leaders and scientists to openly discuss strategies regarding BioAnalytical assay development, BioAnalytical method validation, ligand binding assay development and validation and more.


The 2nd Annual Bioanalytical Method Development will offer you this & more
  • Immunogen, Genentech and Wyeth share novel bioanalytical methods for the use of anti-body drug conjugates to facilitate the development of molecularly targeted cancer therapeutics
  • Three sessions detailing how Genentech, BioMarin, and Human Genome Sciences successfully utilize and implement biomarker assays
  • Half-day of programming devoted to the use of in vitro assessments of Fc effector functionalities to evaluate in vivo efficacy and safety
  • In-depth workshop on Delivering Strategies To Help Generate Meaningful
  • Information On Molecular Interactions To Support Biotherapeutic Development
  • Amgen and Eli Lilly provide case studies on when and how to measuring free and / or total ligand and facilitate open discussion in a half-day workshop

In The News

Loading...

Future of BioPharma

 

Home    Register    Brochure    Send to a Colleague
© 2009 IIR USA, LTD. All Rights Reserved.